Yan Jin

1 month ago | jitc.bmj.com | Yan Jin |Yan Cui |Yongli Jin |Rongzhen Zheng

Chimeric antigen receptor - CARWe read with great interest the article by Xiaojie Liang et al entitled ‘Characteristics of second primary malignancies following bispecific antibodies therapy’.1 The authors should be congratulated for addressing an understudied yet clinically consequential safety issue as bispecific antibodies (BsAbs) transition from early-phase trials to routine practice.

Feb 19, 2025 | theborneopost.com | Yan Jin |Liu Xin

BEIJING (Feb 20): “Confucius, does the phrase ‘To learn and constantly review what one has learned, isn’t that a delight?’ mean that we should frequently review our lessons?”In a fourth grade classroom of Xinyilu Primary School, Qinhuangdao, north China’s Hebei Province, a student posed this question to a virtual figure on the screen. The digital “Confucius”, dressed in traditional attire, nodded gently and replied: “Indeed.

Feb 19, 2025 | en.qstheory.cn | Yan Jin |Liu Xin

by Yan Jin and Liu XinBEIJING -- "Confucius, does the phrase 'To learn and constantly review what one has learned, isn't that a delight?' mean that we should frequently review our lessons?"In a fourth grade classroom of Xinyilu Primary School, Qinhuangdao, north China's Hebei Province, a student posed this question to a virtual figure on the screen. The digital "Confucius," dressed in traditional attire, nodded gently and replied, "Indeed.

Feb 18, 2025 | english.news.cn | Yan Jin |Liu Xin

by Yan Jin and Liu Xin BEIJING, Feb. 18 (Xinhua) -- "Confucius, does the phrase 'To learn and constantly review what one has learned, isn't that a delight?' mean that we should frequently review our lessons?" In a fourth grade classroom of Xinyilu Primary School, Qinhuangdao, north China's Hebei Province, a student posed this question to a virtual figure on the screen. The digital "Confucius," dressed in traditional attire, nodded gently and replied, "Indeed.

Jan 16, 2025 | devblogs.microsoft.com | Yan Jin

The App Compliance Automation Tool (ACAT) in Azure helps to simplify the compliance journey for any app that consumes Microsoft 365 customer data and is published via Partner Center. Natively integrated into the Microsoft 365 Certification framework, ACAT shows customers an app has been vetted against controls derived from leading industry standards, and that strong security and compliance practices are in place to protect customer data.